tanshinone has been researched along with plerixafor in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (plerixafor) | Trials (plerixafor) | Recent Studies (post-2010) (plerixafor) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 1,312 | 113 | 930 |
| Protein | Taxonomy | tanshinone (IC50) | plerixafor (IC50) |
|---|---|---|---|
| C-X-C chemokine receptor type 4 | Rattus norvegicus (Norway rat) | 0.108 | |
| C-C chemokine receptor type 2 | Homo sapiens (human) | 0.0001 | |
| C-X-C chemokine receptor type 4 | Homo sapiens (human) | 0.3717 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Han, H; Hong, D; Qiao, H; Tong, Y; Wu, Y; Xu, W; Yang, J; Zhou, C | 1 |
1 other study(ies) available for tanshinone and plerixafor
| Article | Year |
|---|---|
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
Topics: Abietanes; Animals; Benzylamines; Bone Marrow Cells; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Drugs, Chinese Herbal; Female; Heterocyclic Compounds; Male; Mesenchymal Stem Cells; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Salvia miltiorrhiza; Stem Cell Transplantation; Up-Regulation | 2011 |